# FDA Inspection 822819 - American National Red Cross The - March 15, 2013

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/8c9b6e8f-d9db-4558-b290-b2ad7645f8c4
Source feed: FDA_Inspections

> FDA Inspection 822819 for American National Red Cross The on March 15, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822819
- Company Name: American National Red Cross The
- Inspection Date: 2013-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 735759 - 2011-07-18](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/cb83cea5-1d80-44cd-b5c9-d339e2153800)
- [FDA Inspection 629106 - 2009-11-18](https://www.keypedia.com/records/fda_inspections/american-national-red-cross-the/27ec41b3-7e71-426b-8256-d16b865b20c4)

Company: https://www.keypedia.com/companies/american-national-red-cross-the/3fa68f2d-f514-46cc-8557-d4be866c9ba9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d